Eisai seeks marketing authorisation for Lecanemab to treat early Alzheimer's disease in Great Britain Ruchika Sharma23 May 2023 11:00 AM ISTLecanemab is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of...
Pfizer, Biogen among hundreds of US drugmakers calling for abortion pill Mifepristone ruling reversal Ruchika Sharma11 April 2023 12:15 PM ISTThe FDA approved mifepristone, part of a two-drug regimen that accounts for more than half of US abortions, more than 20 years ago and has determined...
USFDA advisers to weigh full nod for Eisai-Biogen Alzheimer's drug Leqembi Ruchika Sharma11 April 2023 10:00 AM ISTLeqembi belongs to a class of treatments that aim to slow the advance of the neurodegenerative disease by removing sticky clumps of the toxic protein...
USFDA grants priority review for Eisai Alzheimer's drug LEQEMBI Ruchika Sharma8 March 2023 10:00 AM ISTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has accepted Eisai’s supplemental Biologics...
Former Roche Executive Bill Anderson to become new CEO of Bayer Ruchika Sharma9 Feb 2023 4:15 PM ISTLeverkusen: Bill Anderson will become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1,...
Biogen, Sage Therapeutics get USFDA priority review for depression drug Zuranolone Ruchika Sharma7 Feb 2023 1:15 PM ISTZuranolone is an oral neuroactive steroid (NAS) GABA-A receptor positive allosteric modulator (PAM).
Eisai-Biogen Alzheimer's drug Lecanemab should be priced below Aduhelm: Report Ruchika Sharma25 Dec 2022 2:00 PM ISTTreatment with the drug may provide a small or even substantial benefit to patients with early Alzheimer's, but there remains a possibility of net...
Roche to stop all Gantenerumab studies in early Alzheimer's disease Ruchika Sharma2 Dec 2022 2:30 PM ISTRoche is still testing a different formulation of gantenerumab called trontinemab, designed to ferry the drug across the blood brain barrier -...
Sandoz, Teva Pharma plans to ramp up biosimilars production Ruchika Sharma23 Nov 2022 1:30 PM ISTTeva Chief Executive KÃ¥re Schultz said the company was targeting "80% of what's going off-patent in the next 10 years" including big sellers like the...
Former Sandoz Chief Richard Francis joins Teva Pharma as President, CEO Ruchika Sharma22 Nov 2022 1:30 PM ISTPrior to his role at Sandoz, Mr. Francis was a senior executive at Biogen for 13 years where he held a number of senior roles, including leading the...
Former Sanofi head Christopher A Viehbacher appointed as Biogen new President, CEO Ruchika Sharma11 Nov 2022 12:30 PM ISTCambridge: Biogen Inc. has announced that its Board of Directors has appointed Christopher A. Viehbacher as President and Chief Executive Officer and...
Former JnJ executive Mathai Mammen emerges as top candidate to head Biogen as CEO: Report Ruchika Sharma8 Oct 2022 12:15 PM ISTVounatsos is serving as CEO until a successor is appointed.
